{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:23:09Z","timestamp":1777386189904,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Rwanda Ministry of Health","award":["Masters of Medicine Research Grant"],"award-info":[{"award-number":["Masters of Medicine Research Grant"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hypertension management in rural, resource-poor settings is difficult. Detailed understanding of patient, clinician and logistic factors which pose barriers to effective blood pressure control could enable strategies to improve control to be implemented.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This cross-sectional, multifactorial, observational study was conducted at four rural Rwandan district hospitals, examining patient, clinician and logistic factors. Questionnaires were administered to consenting adult outpatient hypertensive patients, obtaining information on sociodemographic factors, past management for hypertension, and adherence (by Morisky Medication Adherence 8-item Scale (MMAS-8). Treating clinicians identified local difficulties in providing hypertension management from a standard World Health Organisation list and nominated their preferred treatment regimens. Blood pressure measurements and other clinical data were collected during the study visit and used to determine blood pressure control, according to goals from JNC-8 guidelines. Medication availability and cost at each hospital\u2019s pharmacy were reviewed as logistic barriers to treatment.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The 112 participating patients were 80% female, with only 41% having completed primary education. Self-reported adherence by the MMAS-8 was high in 77% (86\/112) and significantly associated) with literacy, lack of medication side effects and the particular hospital and pharmacy attended (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). However, of 89 patients with blood pressure data, only 26 (29%) had achieved goal blood pressure. No patient factor were statistically associated with poor blood pressure control. Among 30 participating clinicians, deficiencies in knowledge were evident; 43% (13\/30) and 37% (11\/30) chose a loop diuretic as their prescribed medication and as an ideal medication, respectively, for a newly diagnosed hypertensive patient without comorbidities, counter to JNC 8 recommendations, and 50% (15\/30) identified clinician non-adherence to hypertension guidelines as a barrier. In the pharmacies, common anti-hypertensive medications were affordably available (&gt;\u20096 out of 8 examined medications available in all pharmacies, cost &lt;US$0.50 per month); however, clinicians perceived medication cost and availability to be barriers to care.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Clinician-based factors are a major barrier to blood pressure control in rural district hospitals in Rwanda, and blood pressure control overall was poor. Patient and logistic barriers to blood pressure were not evident in this study.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-019-1203-3","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T16:20:27Z","timestamp":1571674827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Patient, clinician and logistic barriers to blood pressure control among adult hypertensives in rural district hospitals in Rwanda: a cross-sectional study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4479-1994","authenticated-orcid":false,"given":"J. P.","family":"Sibomana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. L.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. D.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,21]]},"reference":[{"key":"1203_CR1","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1053\/j.ajkd.2009.06.044","volume":"55","author":"BV Mittal","year":"2010","unstructured":"Mittal BV, Singh AK. Hypertension in the developing world: challenges and opportunities. Am J Kidney Dis. 2010;55:590\u20138.","journal-title":"Am J Kidney Dis"},{"key":"1203_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.cjca.2014.02.020","volume":"30","author":"KB Tibazarwa","year":"2014","unstructured":"Tibazarwa KB, Damasceno AA. Hypertension in developing countries. Can J Cardiol. 2014;30:527\u201333.","journal-title":"Can J Cardiol"},{"key":"1203_CR3","first-page":"825","volume":"11","author":"AC Ikeme","year":"1989","unstructured":"Ikeme AC. Hypertension studies in developing countries. Clin Exp Hypertens A. 1989;11:825\u201339.","journal-title":"Clin Exp Hypertens A"},{"issue":"5","key":"1203_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"Paul A. James","year":"2014","unstructured":"Chow CK, Teo KK. Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries. JAMA. 2014;311(5):507\u201320. \n                    https:\/\/doi.org\/10.1001\/jama.2013.284427\n                    \n                  .","journal-title":"JAMA"},{"key":"1203_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.7196\/SAMJ.4342","volume":"101","author":"SJ Reid","year":"2011","unstructured":"Reid SJ, Couper ID, Volmink J. Educational factors that influence the urban-rural distribution of health professionals in South Africa: a case-control study. South African Med J. 2011;101:29\u201333.","journal-title":"South African Med J"},{"key":"1203_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1478-4491-2-3","volume":"2","author":"M Vujicic","year":"2004","unstructured":"Vujicic M, Zurn P, Diallo K, Adams O, Dal Poz MR. The role of wages in the migration of health care professionals from developing countries. Hum Resour Health. 2004;2:3.","journal-title":"Hum Resour Health"},{"key":"1203_CR7","first-page":"595","volume":"82","author":"B Stilwell","year":"2004","unstructured":"Stilwell B, et al. Migration of health-care workers from developing countries: strategic approaches to its management. Bull World Health Organ. 2004;82:595\u2013600.","journal-title":"Bull World Health Organ"},{"key":"1203_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint National Committee (JNC 8). JAMA. 2014;311:507\u201320.","journal-title":"JAMA"},{"issue":"1","key":"1203_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1748-0361.2006.00069.x","volume":"23","author":"Zina M. Daniels","year":"2007","unstructured":"Daniels ZM, Vanleit BJ, Skipper BJ, Sanders ML, Rhyne RL. Factors in recruiting and retaining health professionals for rural practice. J Rural Heal. 2007;23:62\u201371.","journal-title":"The Journal of Rural Health"},{"issue":"2","key":"1203_CR10","first-page":"e79","volume":"122","author":"R Pande","year":"2010","unstructured":"Pande R, Niyonzima JP. Prevalence and clinical aspects of hypertension in Ruhengeri district hospital, Musanze, Rwanda. Circulation. 2010;122(2):e79.","journal-title":"Circulation"},{"key":"1203_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.jhh.1002284","volume":"22","author":"G Bakris","year":"2008","unstructured":"Bakris G, et al. Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action. J Hum Hypertens. 2008;22:63\u201370.","journal-title":"J Hum Hypertens"},{"key":"1203_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2165\/00115677-200715040-00006","volume":"15","author":"ND Shah","year":"2007","unstructured":"Shah ND, Steiner ME, Vermeulen LC, Fleming LA, Cory PR. The role of medication adherence as a determinant of blood pressure control in a managed care population. Dis Manage Health Outcomes. 2007;15:249\u201356.","journal-title":"Dis Manage Health Outcomes"},{"key":"1203_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1592\/phco.23.8.1060.32879","volume":"23","author":"TM Romain","year":"2003","unstructured":"Romain TM, Patel RP, Heaberlin AM, Zarowitz BJ. Assessment of factors influencing blood pressure control in a managed care population. Pharmacotherapy. 2003;23:1060\u201370.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"1203_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jclinepi.2010.09.010","volume":"64","author":"Donald E. Morisky","year":"2011","unstructured":"Morisky DE, Dimatteo MR. Improving the measurement of self-reported medication nonadherence: final response. J Clin Epidemiol. 2011. \n                    https:\/\/doi.org\/10.1016\/j.jclinepi.2010.09.010\n                    \n                  .","journal-title":"Journal of Clinical Epidemiology"},{"key":"1203_CR15","unstructured":"Krousel-Wood M, et al. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009;15(1):59\u201366."},{"issue":"5","key":"1203_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","volume":"10","author":"Donald E. Morisky","year":"2008","unstructured":"Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008. \n                    https:\/\/doi.org\/10.1111\/j.1751-7176.2008.07572.x\n                    \n                  .","journal-title":"The Journal of Clinical Hypertension"},{"key":"1203_CR17","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1371\/journal.pmed.0040283","volume":"4","author":"GM Allan","year":"2007","unstructured":"Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: a systematic review. PLoS Med. 2007;4:1486\u201396.","journal-title":"PLoS Med"},{"key":"1203_CR18","first-page":"237(E)","volume":"30","author":"RL Pruitt","year":"1995","unstructured":"Pruitt RL, Hogan T, Malcolm K, Rottas C. Influence of physician education on drug selection and total cost for outpatient antihypertensive therapy. ASHP Midyear Clin. Meet. 1995;30:237(E).","journal-title":"ASHP Midyear Clin. Meet"},{"key":"1203_CR19","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1177\/106002809202600516","volume":"26","author":"JE Sumpton","year":"1992","unstructured":"Sumpton JE, Frewen TC, Rieder MJ. The effect of physician education on knowledge of drug therapeutics and costs. Ann Pharmacother. 1992;26:692\u20137.","journal-title":"Ann Pharmacother"},{"key":"1203_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/sj.jhh.1001778","volume":"19","author":"T Shiner","year":"2005","unstructured":"Shiner T, et al. The financial cost of optimising blood pressure control. J Hum Hypertens. 2005;19:83\u20134.","journal-title":"J Hum Hypertens"},{"key":"1203_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1258\/004947506775598699","volume":"36","author":"CO Alebiosu","year":"2006","unstructured":"Alebiosu CO. Profile of antihypertensive prescription in a developing country. Trop Dr. 2006;36:44\u20136.","journal-title":"Trop Dr"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1203-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-019-1203-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1203-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T23:10:19Z","timestamp":1603149019000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-019-1203-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,21]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1203"],"URL":"https:\/\/doi.org\/10.1186\/s12872-019-1203-3","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,21]]},"assertion":[{"value":"2 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The National University of Rwanda Faculty Ethics Committee approved the study and the National Health Research Committee appointed the National University of Rwanda Faculty of Medicine Ethic Committee to approve the study. Written informed consent was received directly from all (patient and clinician) participants. All involved district hospital and pharmacy directors gave permission to conduct the study in their institutions.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"231"}}